ࡱ> )` Rbjbj2{{d!\\\\\\\px9x9x9x9L9<p_< < < < < < < < <^^^^^^^$`hWc2_]\L < <LL_\\ < <m_\L\L\LL4\ <\ <^\LL^\L\L\\\L << ˹ʚx96L\LfX_0_\LcRLc\L\L:c\L <8DA\LDG < < <__RL < < <_LLLLppppppppp\\\\\\ & Scientific Program BIT s 8th Annual World Congress of Vaccine-2016 Theme: Accelerating the R&D of Next Generation Antibodies Time: April 25-28, 2016 Venue: Dalian International Conference Center (DICC), Dalian, China RegistrationTime: 08:30-18:00, April 24-25, 2016; Place: Dalian International Conference Center (DICC) Group PhotoTime: 08:20-08:30, April 25, 2016 (Monday); Place: South Outside of the Square, DICC Opening Ceremony and Plenary Forum Opening CeremonyTime: 09:00-10:00, April 25, 2016 (Monday); Place: Room 303, 3rd Floor, DICC Plenary ForumTime:10:00-12:10, April 25, 2016 (Monday); Place: Room: 303, 3rd Floor, DICCModeratorDr. Mingde Xia,Senior Director, Johnson & Johnson Innovation, USA10:00-10:05Moderator's Introduction10:05-10:30Title:How to Model the Action of Complex Biological Systems on a Molecular Level Dr. Arieh Warshel,Distinguished Professor, University of Southern California, USA Nobel Prize Laureate in Chemistry, 201310:30-10:55Title:Understanding Human Health and Disease with LC/MS Based Metabolic Phenotyping Prof. Robert Plumb,Professor, Imperial College London, UK Fellow of the Royal Society of Chemistry10:55-11:20Title:A Novel Genetic System for Medical/Biotech Development of Longevity, Juvenescence, And Tumor Resistance Dr. Che-Kun James Shen,Distinguished Research Fellow, Institute of Molecular Biology, Academia Sinica, Taiwan Elected Fellow of the American Association for the Advancement of Science (AAAS) and the Third World Academy of Sciences, Academician of the Academia Sinica11:20-11:45Title:I Demonstrating Biosimilarity-A Foundation of the Biosimilar Development Dr. Patrick Liu,Vice President, Teva Pharmaceuticals Ltd., USA11:45-12:10Title:Bispecific Antibodies Finally Come of Age Dr. William Strohl,Vice President, Janssen Research & Development, LLC, USA Keynote Forum of ICA & WCV & PepConTime: 14:30-17:05, April 25, 2016 (Monday); Place: Room 307, 3rd Floor, DICCModeratorDr. Matthew He,Professor, Nova Southeastern University, USA14:30-14:35Moderator's Introduction14:35-15:05Title:Immunogenicity Assessment of Therapeutic Monoclonal Antibodies C Lab Testing and Clinical Impact Assessment Dr. Patrick Liu,Vice President, Teva Pharmaceuticals Ltd., USA15:05-15:35Title:The Promise of Peptide Drugs to Alleviate Medical Needs Dr. Jose de Chastonay,Chief Marketing Officer, Bachem Holding AG, Switzerland15:35-16:05Title:Present State and Challenges of Peptidomics Dr. Vadim T. Ivanov,Professor, Director, Russian Academy of Sciences, Russia16:05-16:35Title:Production and Purification of Virus like Particle (VLP) Based Vaccine Dr. Priyabrata Pattnaik,Director of Worldwide Vaccine Initiative, Merck , Singapore WCV 01: Global Immunization Projects and Global HealthTime: 11:25-12:30, April 26, 2016 (Tuesday) ; Place: Room 623, 6th Floor, DICCChairDr. Rebecca Martin,Director of the Global Immunization Division (GID), CDC, USA11:25-11:30Chair's Introduction11:30-11:50Title:A Vaccine Pipeline-phage Display for Biomarker Identification and Generation of Human Antibodies for Diagnostics and Therapy Dr. Michael Hust,Professor, Technical University of Braunschweig, Germany11:50-12:10Title:The Antibody Germline/Maturation Hypothesis Dr. Dimiter Dimitrov,Senior Investigator, National Cancer Institute, USA12:10-12:30Title:What Should Be the Next Investment in Global Immunization? Dr. Rebecca Martin,Director of the Global Immunization Division (GID), CDC, USA12: 30-13:30Lunch WCV 02: Novel Vaccine Technology and ApproachesTime: 13:30-17:10, April 26, 2016 (Tuesday) ; Place: Room 624, 6th Floor, DICCChairDr. Philip R. Hardwidge,Associate Professor, Kansas State University, USACo-ChairDr. Ming Tan,Assistant Professor, University of Cincinnati College of Medicine, USA13:30-13:35Chair's Introduction13:35-13:55Title:Mucosal Vaccine Design to Control Fertility Using Dendritic Lhrh Antigens and Polyelectrolyte Coated Liposome Delivery Systems against GroupA Streptococcus (GAS) Infection Dr. Istvan Toth,Professor, University of Queensland, Australia13:55-14:15Title:Protective Efficacy of Enterotoxigenic E. Coli Antigens Dr. Philip R. Hardwidge,Associate Professor, Kansas State University, USA14:15-14:35Title:Development of Lipid Core Peptide-based Vaccines against Necator Americanus and Schistosoma Mansoni Dr. Mariusz Skwarczynski,Fellow, University of Queensland, Australia14:35-14:55Title:Lipovaxin, Nano-particulate Chelating Lipid-based Immunostimulatory Particles for Improved Recombinant Vaccine Formulations Dr. Ines Atmosukarto,Chief Executive Officer, Lipotek Pty. Ltd., Australia14:55-15:15Title:Vaccinia Based Vaccine Platform Dr. Jiahu Wang,Principal, Ottawa Hospital Reseach Institute, Canada15:15-15:30Coffee Break15:30-15:50Title:Bi- and Trivalent Vaccines against Enterically Transmitted Hepatitis E Virus, Norovirus and Astrovirus Dr. Ming Tan,Assistant Professor, University of Cincinnati College of Medicine, USA15:50-16:10Title:Long Term Persistence of Immunogenicity of Single Dose Live Attenuated Hepatitis a Vaccine: Indian Perspective Dr. Monjori Mitra,Director, Medclin Research Pvt. Ltd., India16:10-16:30Title:Innovation in Cell Culture Scale-up Technology Dr. Ziqiu Guan,FAS Manager, Corning Life Sciences, China16:30-16:50Title:MEFA (Multiepitope Fusion Antigen) for Multivalent Vaccines Broadly Protecting against Enterotoxigenic Escherichia Coli-associated Children's Diarrhea and Travelers' Diarrhea Dr. Weiping Zhang,Professor, Kansas State University, USA16:50-17:10Title:New Technology in Vaccine Process Development Ms. Hongyan Xie,Bioprocess Modality Manager, GE Healthcare LS, China17:10-18:00Panel Discussion WCV 03: Human Vaccine For Infectious DiseasesTime: 08:30-11:50,April 27, 2016 (Wednesday) ; Place: Room 624, 6th Floor, DICCChairDr. Xiangguo Qiu,Head,Public Health Agency of Canada, CanadaCo-ChairDr. Ahdi Amer,Associate Professor, Wayne State University School of Medicine, USA08:30-08:35Chair's Introduction08:35-08:55Title:Important Topics on Human Vaccines and Vaccination for Non-infectious Diseases Dr. Giulio Filippo Tarro,Professor, Foundation de Beaumont Bonelli for Cancer Research, Italy08:55-09:15Title:Targeted Multimodal Cancer Nanovaccine Dr. Luis Javier Cruz,Group Leader, Leiden University Medical Center, The Netherlands09:15-09:35Title:The Development and Application of VSVG-EBOV-GP Vaccine Dr. Xiangguo Qiu,Head, National Microbiology Laboratory, Canada09:35-09:55Title:Prevalence of the Flu Vaccination in a Working Population Dr. Frdric Deschamps,Director, Medicine Faculty of Reims, France10:15-10:30Coffee Break10:30-10:50Title:Invasive Meningococcal Disease in US and the Rationale for the Current Meningococcal Vaccine Policies Dr. Ahdi Amer,Associate Professor, Wayne State University School of Medicine, USA10:50-11:10Title:Research & Development of Monovalent Influenzaa H7N9 Vaccine Dr. Penghui Yang,Associate Professor, Beijing Institute of Microbiology and Epidemiology, China11:10-11:30Title:HCV-induced Myeloid-derived Suppressor Cells Control T Cell Differentiation through miR-124-mediated STAT-3 Signaling Dr. Zhi Q. Yao,Director, East Tennessee State University, USA11:30-11:50Title:Rapidly Separating Microneedles for Transdermal Vaccine Delivery Dr. Xindong Guo,Professor, Beijing University of Chemical Technology, China12:30-13:30Lunch WCV 04: Veterinary VaccineTime: 11:00-12:25, April 28, 2016 (Thursday) ; Place: Room 621, 6th Floor, DICCChairDr. Panagiotis Karanis,Professor, Qinghai University, China11:00-11:05Chair's Introduction11:05-11:25Title:*8<> ʲiQ6"&hh5CJKHOJQJ\^J5hh56B*CJKHOJQJ\]^Jph/hh5B*CJKHOJQJ\^Jphf/hh5B*CJKHOJQJ\^Jph-hhB*CJKHOJQJ^JaJph2hh5B*CJH*KHOJQJ\^Jphfff/hh5B*CJKHOJQJ\^Jphfff3hh5B*CJKHOJQJ\^JaJph6hh5B*CJKHOJQJ\^JaJo(ph *> H ?ukd$$If<   0634<abp yt dF$1$Ifgd$d9-D1$M a$gddF-D1$M gd$d-D1$M a$gd G H I K V W X 1 2 3 5 B C D I J      d e x ⷣⷋⷣttt,hh56CJKHOJQJ\]^J/hh5B*CJKHOJQJ\^Jph&hh5CJKHOJQJ\^J-hhB*CJKHOJQJ^JaJph&hh6CJKHOJQJ]^JhhCJKHaJ hhCJKHOJQJ^J-H I K W y dF$1$IfgddF-D1$M gdfkd$$If< 0634<abytW X { dF$1$Ifgdukd$$If<   0634<abp yt y dF$1$IfgddF-D1$M gdfkdN$$If< 0634<abyt 2 { dF$1$Ifgdukd$$If<   0634<abp yt2 3 5 C y dF$1$IfgddF-D1$M gdfkd$$If< 0634<abytC D { dF$1$Ifgdukd}$$If<   0634<abp yt } dF$1$Ifgd $$1$Ifa$gdfkdL$$If< 0634<abyt  vh dF$1$Ifgd $$1$Ifa$gd{kd$$If<0s 0634<abyt   vh dF$1$Ifgd $$1$Ifa$gd{kd$$If<0s 0634<abyt vh dF$1$Ifgd $$1$Ifa$gd{kd$$If<0s 0634<abyt A B V !":./;B VWY|}~ 89:FM˷˷˷˷˷˷&hh5CJKHOJQJ\^J-hhB*CJKHOJQJ^JaJph&hh6CJKHOJQJ]^J,hh56CJKHOJQJ\]^J hhCJKHOJQJ^JhhCJKHaJ1 .vh dF$1$Ifgd $$1$Ifa$gd{kd>$$If<0s 0634<abyt./;vh dF$1$Ifgd $$1$Ifa$gd{kd$$If<0s 0634<abytVvh dF$1$Ifgd $$1$Ifa$gd{kd $$If<0s 0634<abytVWY}rd dF$1$IfgddF-D1$M gd{kdx $$If<0s 0634<abyt}~%fkd $$If< 0634<abyt dF$1$Ifgdfkd6 $$If< 0634<abyt 9h{kd $$If<0s 0634<abyt dF$1$Ifgd $$1$Ifa$gd9:Fvh dF$1$Ifgd $$1$Ifa$gd{kdP $$If<0s 0634<abytZ\~rt  HI^ GHJ)*6JKLX_ǰǣǰǰǣǰǰǣǰǰǣxǣǣxǰǣxǣǰ&hh5CJKHOJQJ\^J-hhB*CJKHOJQJ^JaJphhhCJKHaJ,hh56CJKHOJQJ\]^J hhCJKHOJQJ^J&hh6CJKHOJQJ]^J&hh6CJKHOJQJ]^J/ vh dF$1$Ifgd $$1$Ifa$gd{kd$$If<0s 0634<abyt  vh dF$1$Ifgd $$1$Ifa$gd{kd$$If<0s 0634<abytGvh dF$1$Ifgd $$1$Ifa$gd{kd$$If<0s 0634<abytGHJra$d9$1$Ifa$gddF-D1$M gd{kdH$$If<0s 0634<abytx$d9$1$Ifa$gdukd$$If<   0634<abp yt)w$d9$1$Ifa$gd$d9$1$Ifa$gdfkd$$If< 0634<abyt)*6Ksb$d9$1$Ifa$gd$d9$1$Ifa$gd{kdy$$If<0s 0634<abytKLX'sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd?$$If<0s 0634<abyt_'(4:g}QR_defh:;CDR| !ķķķģķķķķķģķķ-hhB*CJKHOJQJ^JaJph&hh5CJKHOJQJ\^JhhCJKHaJ hhCJKHOJQJ^J,hh56CJKHOJQJ\]^J&hh6CJKHOJQJ]^J7'(4sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd$$If<0s 0634<abytQsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd$$If<0s 0634<abytQR_ess$d9$1$Ifa$gd{kdy$$If<0s 0634<abytefhra$d9$1$Ifa$gddF-D1$M gd{kd7$$If<0s 0634<abytx$d9$1$Ifa$gdukd$$If<   0634<abp yt:w$d9$1$Ifa$gd$d9$1$Ifa$gdfkd$$If< 0634<abyt:;Dsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kdh$$If<0s 0634<abytsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd.$$If<0s 0634<abytsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd$$If<0s 0634<abytSsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd$$If<0s 0634<abyt!ST`g$!1fgs PQ]d&UeQ R c d !!"!2!3!4!˷ˣ˷˷˷˷˷ˣ˷&hh5CJKHOJQJ\^J&hh6CJKHOJQJ]^J,hh56CJKHOJQJ\]^JhhCJKHaJ hhCJKHOJQJ^J?ST`sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kdh$$If<0s 0634<abytsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd&$$If<0s 0634<abytfsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd$$If<0s 0634<abytfgsss$d9$1$Ifa$gd{kd$$If<0s 0634<abytPsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd`$$If<0s 0634<abytPQ]sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd$$If<0s 0634<abytsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd$$If<0s 0634<abyt sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd $$If<0s 0634<abyt !sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kdX!$$If<0s 0634<abyt!!"!3!ss$d9$1$Ifa$gd{kd"$$If<0s 0634<abyt3!4!6!d!ra$d9$1$Ifa$gddF-D1$M gd{kd"$$If<0s 0634<abyt4!6!c!d!e!v!w!!!!!!!!!!!!""""Y"Z"f"z"{"|""""""=#>#J#Q#x######4$X$$$$$R%%%%%%öâöËöËööËöËöËöËö,hh56CJKHOJQJ\]^J&hh6CJKHOJQJ]^JhhCJKHaJ hhCJKHOJQJ^J&hh5CJKHOJQJ\^J-hhB*CJKHOJQJ^JaJph6d!e!!x$d9$1$Ifa$gdukd#$$If<   0634<abp yt!!!!w$d9$1$Ifa$gd$d9$1$Ifa$gdfkd[$$$If< 0634<abyt!!"Y"sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd%$$If<0s 0634<abytY"Z"f"{"sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd%$$If<0s 0634<abyt{"|""=#sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd&$$If<0s 0634<abyt=#>#J##sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kdG'$$If<0s 0634<abyt###$sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd($$If<0s 0634<abyt$$$%sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd($$If<0s 0634<abyt%%%&sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd)$$If<0s 0634<abyt%&&&&&&&&&&&&&&'8'''''(( (P(Q(](d((((((())))")#)$)s)t)u)z){))))))))))۷۷۷۷۷۷ΌΣ۷۷U-hhB*CJKHOJQJ^JaJph&hh6CJKHOJQJ]^J,hh56CJKHOJQJ\]^JhhCJKHaJ hhCJKHOJQJ^J&hh5CJKHOJQJ\^J6&&&&se dF$1$Ifgd$d9$1$Ifa$gd{kd?*$$If<0s 0634<abyt&&&'se dF$1$Ifgd$d9$1$Ifa$gd{kd*$$If<0s 0634<abyt'''P(se dF$1$Ifgd$d9$1$Ifa$gd{kd+$$If<0s 0634<abytP(Q(]((sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kdy,$$If<0s 0634<abyt((()ss$d9$1$Ifa$gd{kd7-$$If<0s 0634<abyt)))#)ra$d9$1$Ifa$gddF-D1$M gd{kd-$$If<0s 0634<abyt#)$)t)x$d9$1$Ifa$gdukd.$$If<   0634<abp ytt)u){))w$d9$1$Ifa$gd$d9$1$Ifa$gdfkd|/$$If< 0634<abyt))))sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd&0$$If<0 0634<abyt)))se dF$1$Ifgd$d9$1$Ifa$gd{kd0$$If<0 0634<abytIntroduction ofa Novel Recombinant Chimeric Vaccine Composed of PRRSV Antigens and Truncated Form of Pseudomonas Exotoxin A (PE-K3) Dr. Chao-Wei Liao,CEO, Yao Yang Corporation, Taiwan11:25-11:45Title:Two Approaches to Prevention of Staphylococcal Mastitis in Dairy Cows by Vaccine Dr. Gabriel Leitner,Head, Kimron Veterinary Institute, Israel11:45-12:05Title:Cryptosporidium and Its Long Road to Recognition as an Important Human Pathogen Dr. Panagiotis Karanis,Professor, Qinghai University, China12:05-12:25Title:Nanoparticulate Adjuvant Enhances Potent Immune Responses by Staphylococcus Aureus-bacterins and rDNA Produced Proteins Detected in Serum and Milk Dr. Bror Morein,Professor,Savacc Av, Sweden12:30-13:30Lunch 5_`ls ķķķķģķha>P&hh5CJKHOJQJ\^JhhCJKHaJ hhCJKHOJQJ^J,hh56CJKHOJQJ\]^J&hh6CJKHOJQJ]^J_sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd1$$If<0 0634<abyt_`lsb$d9$1$Ifa$gd$d9$1$Ifa$gd{kdh2$$If<0 0634<abyt sb$d9$1$Ifa$gd$d9$1$Ifa$gd{kd&3$$If<0 0634<abytss$d9$1$Ifa$gd{kd3$$If<0 0634<abyt{kd4$$If<0 0634<abyt0182P. A!"#$%S $$If!vh5!#v!:V <  06,5/  / 34<p yt$$If!vh5!#v!:V <06,5/  / 34<yt$$If!vh5!#v!:V <  06,5/  / 34<p yt$$If!vh5!#v!:V <06,5/  / 34<yt$$If!vh5!#v!:V <  06,5/  / 34<p yt$$If!vh5!#v!:V <06,5/  / 34<yt$$If!vh5!#v!:V <  06,5/  / 34<p yt$$If!vh5!#v!:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,55/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh5!#v!:V <065/  / 34<yt$$If!vh5!#v!:V <065/  / 34<yt$$If!vh55J#v#vJ:V <06,55/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh5!#v!:V <  065/  / 34<p yt$$If!vh5!#v!:V <065/  / 34<yt$$If!vh55J#v#vJ:V <06,55/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh5!#v!:V <  065/  / 34<p yt$$If!vh5!#v!:V <065/  / 34<yt$$If!vh55J#v#vJ:V <06,55/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh5!#v!:V <  065/  / 34<p yt$$If!vh5!#v!:V <065/  / 34<yt$$If!vh55J#v#vJ:V <06,55/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh55J#v#vJ:V <06,5/  / 34<yt$$If!vh5!#v!:V <  065/  / 34<p yt$$If!vh5!#v!:V <065/  / 34<yt$$If!vh565#v6#v:V <06,55/  / 34<yt$$If!vh565#v6#v:V <06,5/  / 34<yt$$If!vh565#v6#v:V <06,5/  / 34<yt$$If!vh565#v6#v:V <06,5/  / 34<yt$$If!vh565#v6#v:V <06,5/  / 34<yt$$If!vh565#v6#v:V <06,5/  / 34<yt$$If!vh565#v6#v:V <06,5/  / 34<ytN@N cke $1$a$$CJKHPJ_HaJmH nHsH tH$A@$ ؞k=W[SOBi@B nfh J $%tu{%&2GHTHIUyz  (&BCIYZfyz`am ~DEQfgs45Bz { O!P!\!b!c!f!0000000 @0 00 @0 0000 @0 00 @0 00000 @0 00 @0 0000 00 00 00 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 0000 00 00 00 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 0000 00 00 00 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 0000 00 00 00 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 0000 00 00 00 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 0000 00 00 00 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 00 00 @0 0HIKWX235CD./;VWY}~ 9:F # $ 0  ] ^ d = > J $%tu{%&2GHTHIUyz  (&BCIYZfyz`am ~DEQfgs45Bz { O!P!\!b!c!f!00000@ 0 00@ 0A 000@ 0  0 0 @ 0Ct 00@ 000 00@<<<< 00@ 00 00A 00@ 00A4: 0 @t$ 0"0"h8 0$0$Ĕ 0&0&@vgj 0(0(@kck[ 0*0*@lli 0,0,@rS:P 0.0.<<<< 00@9 0202@t 0404@ 0606tx  0808@t 0:0:@\ 0<0<@ȑ0 0>0>@< 0@@ 0B0B@h 0D0D@ 0F0F@ ȑ00 0H"0H"@ȑ00 0J"0J"@ȑ00 0L"0L"@ȑ00 0N"0N"@ ʑ00 0P"0P"@P0 0R"0R"@ȑ00 0T"0T"@ ʑ00 0V"0V"@P0 0X"0X"@ 0Z0Z@ 0\0\@ 0^0^@ 0`0`@ 0b@ 0d0d@ 0f0f@ 0h0h@ 0j0j@ 0l0l@ 0n0n@ 0p0p@ 0r0r@ 0t0t@ 0v0v@ 0x0x@ 0z0z@ 0|0|@ 0~0~@ 0@ 00@ 00@ 00@ 00@ 00@ 00@ 00@ 0c! _!4!%#+4?KUbH W 2 C  .V}9 G)K'Qe:SfP !3!d!!!Y"{"=##$%&&'P(()#)t)))_ !"$%&'()*,-./012356789:;<=>@ABCDEFGHIJLMNOPQRSTVWXYZ[\]^_cdefg_JY syJYLsyJYsyJYsyJY tyJYLtyJYtyJYtyJY uyJYLuyJYuyJYuyJY vyJYLvyJYvyJYvyJY wyJYLwyJYwyJYwyJY xyJYLxyJYxyJYxyJY yyJYLyyJYyyJYyyJY zyJYLzyJYzyJYzyJY {yJYL{yJY{yJY{yJY |yJYL|yJY|yJY|yJY }yJYL}yJY}yJY}yJY ~yJYL~yJY~yJY~yJY yJYLyKYyKYyKYyKYTyKYyKYԀyKYyKYTyKYy KYԁy KYy KYTy KYy KYԂyKYyKYTyKYyKYԃyKYyKYTyKYyKYԄyKYyKYTyKYyKYԅyKYyKYTyKYyKYԆyKYyKYTy KYy!KYԇy"KYy#KYTy$KYy%KYԈy&KYy'KYTy(KYy)KYԉy*KYy+KYTy,KYy!/:__ajrrzMMR    p p 9 9   !$$>CCyy||` ` t f!      !"#$%&'()+*,.-/0132465789;:<>=?A@BCDFEGHIJKLMONPQRSTUVXWYZ[]\^ .9@@hhiqx||PUU    " " < <  $$<GGZZr y y f!    !"#$%&'()+*,.-/0132465789;:<>=?A@BCDFEGHIJKLMONPQRSTUVXWYZ[]\^:P*urn:schemas-microsoft-com:office:smarttagsStreet;Q*urn:schemas-microsoft-com:office:smarttagsaddress=\*urn:schemas-microsoft-com:office:smarttags PlaceType=_*urn:schemas-microsoft-com:office:smarttags PlaceName8Z*urn:schemas-microsoft-com:office:smarttagsCityBY*urn:schemas-microsoft-com:office:smarttagscountry-region9[*urn:schemas-microsoft-com:office:smarttagsplace H___\[ZY[___\[YQP[ZY_\[ZY[Y[ZY[ZY[Y_\_\[YQP[ZY[ZY[Y[ZY[ZY\_[ZY[ZY[ZYQP[ZY[YQP\_[ZY[YQP[Y[ZY[Y[ZYRD!f!5f!f!u.sru.!{u.III{7"CvIIDG_um IYo")9u=mOT`7Yc[**hh0yi{O E h ! ` D}   ' h& '( % xK T - =L S[5lw1*<|CJ,.86RYboet  Tw"H%`hP^y Pp.()]b)MbR c i #!bz!g1"m"iX#$-$S$g$#%%pV%-&2&I&W&h&]*'1'8'P'^*(])H})*I*V*OZ,s_,-|X-2/2=2Gm2y2m+3=3N3D4j4X5w56G6 6;f675(7 :7u7|78:*8.H81%9`9:;-f;<<U<y< ==<$>v>z>5b?&2@dB@{@9AvfABBI0B7B;BSTBaC+C@CUgCDODEC8EPEcE>FLFWG[G#G-@GGGQGH'HT=H5iHW"IZJJ*UJpJwJwJ|K fKGLIL_LMekMuMezM@NSN OiOPa>PTUP)Q/Q'#RIREbRvSM T,-T^TUcUnUyU?VU\V{V!WgW~xW X4Y7Y mYe[E[Q[r[j\A\G\[L\P\Uf\{\ ]w]8^o^| _[;_`)`P`a5adaqaECbqc!cd d d'did*eR1eFeZe;|efVCfPfapf*)gigc#ha&h3,hW,h}.hehP$ikizinjADjgYjk()k`lOmqn Bn[nhnTooQoIpp?qr)rQ0r4rYtrkwr`)sR3suJvPKvSvcvw)w=wRw>[wyiwwKx{)xDBx`UxcxyfyRz{${E{d{0y{||l.| @|\|q}RgeOj'z#  gj(IE4!*5).+"Av $)?D 06L(5a<FkrW!rD%0;:dC|Qh*p4>1Ct } _]fr>x7YpY(-=]'Ar3-{t:Dn*;cLwt 9\q7MAabhsG">:WIaU:(9OS!W,ZZ}-]|eS ^B;c%15?q8V! 0[ehuEI{>h8^Q=RV_a z(NMx %Kd;!J-G=Y/0"Wk4P+iFtKRZfR,L6Y|b=w"FPIi|Vn&7t:Q1px$x|}t||2"E;Q'1,;BHgQTQUl%_8G#S=BLWu$Y'aw  35z~J!O, 2OMTZ_n|/;BRqi"g/o^eEl_w"l'&CX(o8W] &$C)s_Q `e)8L m6*BP jogL]] _`R/%;?DJRyWyop~y%=d??_Ynzs#6Cr CR[Gu~@B[vn,7W^5;Z &9I*A\x!je #3$ @Aha1xEUwQ`W{v&C`T^q 5((5nD4FHw|#4zP <9.J?z?FS_=KRUfk3l:nHIKWX235CD./;VWY}~ 9:F # $ 0  ] ^ d = > J $%tu{%&2GHTHIUyz  (&BCIYZfyz`am ~DEQfgs45Bz { O!P!\!b!c!f!@c!c!ԇ c!c!X zd!@@@@@(@@$@L@@@UnknownGz Times New Roman5Symbol3& z Arial;[SOSimSunI& ??Arial Unicode MS 1hDgDgi<i<-!),.:;?]}    & 6"0000 0 0 00000 =@\]^([{  0 0 00000;[S!S!2HX(?2gr71Oh+'0h  $ 0 <HPX` Normal.dotgr712Microsoft Office Word@@ʚ@ʚi՜.+,D՜.+,|8   (0<S!' ` ?GKSOProductBuildVer2052-9.1.0.3914  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghjklmnopqrstuvwxyz{|}~Root Entry F`ʚData i`51TablecWordDocument2SummaryInformation(DocumentSummaryInformation8CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q